Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Hurley

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
JMIR Human Factors|May 27, 2025
An Informatics-Based, Payer-Led, Low-Intensity Multichannel Educational Campaign Designed to Decrease Postdischarge Utilization for Medicare Advantage Members: Retrospective EvaluationDanica Fernandes, Elise Kokonas, Jai Bansal, et al.
Journal of Medicinal Chemistry|April 6, 2021
Use of Intramolecular 1,5-Sulfur-Oxygen and 1,5-Sulfur-Halogen Interactions in the Design of <i>N</i>-Methyl-5-aryl-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine SMN2 Splicing ModulatorsJake Axford, Moo Je Sung, John Manchester, et al.
Psychiatric Services (Washington, D.C.)|July 20, 2021
Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment WillingnessAllison J Ober, Sarah B Hunter, Colleen M McCullough, et al.
JMIR Human Factors|March 31, 2025
An Informatics-Based, Payer-Led, Low-Intensity Multichannel Educational Campaign Decreases Post-Discharge Utilization in Medicare Advantage MembersDanica Fernandes, Elise Kokonas, Jai Bansal, et al.
Journal of Medical Regulation|October 19, 2016
The Growing Regulation of Conversion TherapyJack Drescher, Alan Schwartz, Flávio Casoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitorTammie C Yeh, Vivienne Marsh, Bryan A Bernat, et al.
Journal of Medicinal Chemistry|November 9, 2018
Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)Atwood K Cheung, Brian Hurley, Ryan Kerrigan, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
JMIR Human Factors|May 27, 2025
An Informatics-Based, Payer-Led, Low-Intensity Multichannel Educational Campaign Designed to Decrease Postdischarge Utilization for Medicare Advantage Members: Retrospective EvaluationDanica Fernandes, Elise Kokonas, Jai Bansal, et al.
Journal of Medicinal Chemistry|April 6, 2021
Use of Intramolecular 1,5-Sulfur-Oxygen and 1,5-Sulfur-Halogen Interactions in the Design of <i>N</i>-Methyl-5-aryl-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine SMN2 Splicing ModulatorsJake Axford, Moo Je Sung, John Manchester, et al.
Psychiatric Services (Washington, D.C.)|July 20, 2021
Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment WillingnessAllison J Ober, Sarah B Hunter, Colleen M McCullough, et al.
JMIR Human Factors|March 31, 2025
An Informatics-Based, Payer-Led, Low-Intensity Multichannel Educational Campaign Decreases Post-Discharge Utilization in Medicare Advantage MembersDanica Fernandes, Elise Kokonas, Jai Bansal, et al.
Journal of Medical Regulation|October 19, 2016
The Growing Regulation of Conversion TherapyJack Drescher, Alan Schwartz, Flávio Casoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitorTammie C Yeh, Vivienne Marsh, Bryan A Bernat, et al.
Journal of Medicinal Chemistry|November 9, 2018
Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)Atwood K Cheung, Brian Hurley, Ryan Kerrigan, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 4